Tinnitus Treatment With Cochlear Implant in Single Sided Deafness
NCT ID: NCT02966366
Last Updated: 2018-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
27 participants
INTERVENTIONAL
2013-08-27
2017-03-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimizing Bilateral and Single-sided-deafness Cochlear Implants for Functioning in Complex Auditory Environments
NCT06305039
Single-Sided Deafness in the Medicare Population
NCT05250414
Single-sided Deafness and Cochlear Implants
NCT01749592
Cochlear Implantation in Pediatric Cases of Unilateral Hearing Loss
NCT02963974
Cerebral Activation and Bilateral Stimulation by Cochlear Implantation in Bilateral Deaf Adults
NCT02904187
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: This study aims to assess the effect of CI electrical stimulation on tinnitus, speech-in-noise and speech-in-quiet abilities in a group of 30 SSD patients.
Methods: After cochlear implantation, patients are stimulated using continuous white noise stimulation in the first month period and thereafter using a conventional stimulation. This was done to investigate the effects of non-meaningful, and therefore only peripheral, stimulation. Outcomes were monitored at 1, 3, 6 and 12 months of CI use. Tinnitus loudness and annoyance were measured with a Visual Analog Scale and tinnitus distress and quality of life were evaluated with tinnitus questionnaires (THI, TRQ and STSS). Speech in noise comprehension was assessed in three different spatial listening configurations and speech in quiet was evaluated through direct connection with the speech processor.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cochlear implantation
Evaluation of tinnitus before and after cochlear implantation
Cochlear implant
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cochlear implant
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Profound to total single sided deafness with associated tinnitus
* Normal or near-normal hearing on contralateral ear
* Tinnitus evaluated by THI ≥ 58 and VAS on annoyance ≥8
* Failure of usual tinnitus treatments
* Duration of tinnitus between 1 and 15 years
* Normal vestibular function of contralateral ear
* Native of fluent French speaker
Exclusion Criteria
* Retrocochlear pathology (vestibular schwannoma, severe central auditory processing disorder)
* Cochlear ossification
* Middle ear pathology
* Tinnitus not related to deafness
* Depression with BDI (Beck Depression Inventory) \> 16 or unfavorable advice from psychologist/ psychiatrist
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oticon Medical
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dan Gnansia, Dr
Role: STUDY_DIRECTOR
Oticon Medical
Bruno Frachet, Pr
Role: PRINCIPAL_INVESTIGATOR
Hôpital Rothschild
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU Lille Hôpital Roger Salengro
Lille, , France
CHU Lyon Hôpital Edouard Herriot
Lyon, , France
Hôpital la Pitié Salpêtrièr
Paris, , France
Hôpital Rothschild
Paris, , France
CHU Rennes Pontchaillou
Rennes, , France
CHU Tours Bretonneau
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PIC_02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.